Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Coronavirus Update: Vir, WuXi Terminate COVID-19 Antibody Pact

May 23 2022

• By Scrip Team

• Source: Shutterstock

Related Content

Moderna Looks To Catch Up In COVID-19 For Kids, While Still Branching Out In Other Areas

Mar 23 2022

US Restricts Use of GSK/Vir’s Xevudy, Deemed ‘Unlikely’ To Help Against Rising Omicron Variant

Mar 28 2022

Pfizer/BioNTech Prepares COVID-19 Vaccine Booster For Children 5-11

Apr 14 2022

Podcast: Ocugen CEO Musunuri On Gene Therapy Candidates, The Omicron Advantage

Dec 22 2021

Coronavirus Update: Japan Paxlovid Approval, US Lifts Covaxin IND Hold

Feb 22 2022

Related Companies

Vir Biotechnology, Inc.

WuXi Biologics

Regeneron Pharmaceuticals, Inc.

Eli Lilly and Company

Alnylam Pharmaceuticals Inc.

Ocugen Inc.

Bharat Biotech

Pfizer Inc.

BioNTech SE

Moderna, Inc.

Additional Topics

Coronavirus COVID-19 Vaccines Research & Development Infectious Diseases BioPharmaceutical

More from COVID-19

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window